Related Experiment Video
Updated: Aug 18, 2026

Oligopeptide Competition Assay for Phosphorylation Site Determination
Published on: May 18, 2017
Structure of S6 kinase 1 determines whether raptor-mTOR or rictor-mTOR phosphorylates its hydrophobic motif site
Siraj M Ali1, David M Sabatini
1Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology, Department of Biology, Cambridge, 02142, USA.
Abstract:
The mTOR protein kinase is the target of the immunosuppressive and anti-cancer drug rapamycin and is increasingly recognized as a key regulator of cell growth in mammals. S6 kinase 1 (S6K1) is the best characterized effector of mTOR, and its regulation serves as a model for mTOR signaling. Nutrients and growth factors activate S6K1 by inducing the phosphorylation of threonine 389 in the hydrophobic motif of S6K1. As phosphorylation of Thr(389) is rapamycin sensitive and mTOR can phosphorylate the same site in vitro, it has been suggested that mTOR is the physiological Thr(389) kinase. This proposal is not supported, however, by the existence of mutants of S6K1 that are phosphorylated in vivo on Thr(389) in a rapamycin-resistant fashion. Here, we demonstrate that the raptor-mTOR complex phosphorylates the rapamycin-sensitive forms of S6K1, while the distinct rictor-mTOR complex phosphorylates the rapamycin-resistant mutants of S6K1. Phosphorylation of Thr(389) by rictor-mTOR is independent of the TOR signaling motif and depends on removal of the carboxyl terminal domain of S6K1. Because many members of the AGC family of kinases lack an analogous domain, rictor-mTOR may phosphorylate the hydrophobic motifs of other kinases.
Insights
The mechanistic target of rapamycin (mTOR) pathway regulates cell growth. This study shows distinct mTOR complexes, raptor-mTOR and rictor-mTOR, differentially phosphorylate S6 kinase 1 (S6K1), clarifying mTOR signaling.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- The mechanistic target of rapamycin (mTOR) is a key regulator of cell growth.
- S6 kinase 1 (S6K1) is a well-studied mTOR effector, and its phosphorylation at threonine 389 (Thr389) is a model for mTOR signaling.
- Rapamycin sensitivity of Thr389 phosphorylation suggests mTOR is the kinase, but rapamycin-resistant S6K1 mutants challenge this.
Purpose of the Study:
- To investigate the roles of distinct mTOR complexes in S6K1 phosphorylation.
- To elucidate the mechanisms underlying rapamycin-sensitive and rapamycin-resistant S6K1 phosphorylation.
- To determine if rictor-mTOR phosphorylates other kinases.
Main Methods:
- Utilized rapamycin-sensitive and rapamycin-resistant S6K1 mutants.
- Investigated phosphorylation by raptor-mTOR and rictor-mTOR complexes.
- Analyzed the role of the carboxyl-terminal domain in rictor-mTOR phosphorylation.
Main Results:
- The raptor-mTOR complex phosphorylates rapamycin-sensitive S6K1.
- The rictor-mTOR complex phosphorylates rapamycin-resistant S6K1 mutants.
- Rictor-mTOR phosphorylation of Thr389 is independent of the TOR signaling motif and requires carboxyl-terminal domain removal.
Conclusions:
- Distinct mTOR complexes (raptor-mTOR and rictor-mTOR) have specific roles in S6K1 regulation.
- Rictor-mTOR may phosphorylate hydrophobic motifs in other AGC family kinases.
- This research clarifies mTOR signaling pathways and their regulation.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Receptor Tyrosine Kinases
The JAK-STAT Signaling Pathway
Amplifying Signals via Enzymatic Cascade

